Global Safety Lancets Market Projected to Reach USD 4.95 Billion by 2035 – SNS Insider [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Austin, United States, April 27, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Safety Lancets Market size was valued at USD 1.71 billion in 2025 and is projected to reach USD 4.95 billion by 2035 and grow at a CAGR of 11.21% over 2026-2035. The growing prevalence of chronic illnesses, particularly diabetes, which calls for regular blood glucose monitoring and hence sustains demand for safety lancets in both clinical and home settings, is driving the expansion of the safety lancets market. Market Size and Forecast: Market Size (2025): USD 1.71 Billion Market Size (2035): USD 4.95 Billion CAGR (2026–2035): 11.21% Base Year: 2025 Forecast Period: 2026–2035 Historical Data: 2022–2024 Safety Lancets Market Get a Sample Report of Safety Lancets Market: https://www.snsinsider.com/sample-request/9311 The U.S. Safety Lancets Market size is USD 0.46 Billion in 2025 and is expected to reach USD 1.31 Billion by 2035, growing at a CAGR of 11.04% over the forecast peri
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform [Yahoo! Finance]Yahoo! Finance
- How to Pick a Healthcare Stock That Can Weather Any Market [Yahoo! Finance]Yahoo! Finance
- How to Pick a Healthcare Stock That Can Weather Any Market [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform [TheStreet.com]TheStreet.com
- Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platformPR Newswire
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/28/26 - Form 4
- 4/28/26 - Form 3
- 4/28/26 - Form 4
- ABT's page on the SEC website